NextCure Inc. (NASDAQ:NXTC)
Old Forum Content for NXTC
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- Bert953: #Squeezes Quite a few tight squeezes. $ISRG $TMO $NEE $PGR $YUM $ADSK $PFE $BRO $WKHS $ADBE $AMZN $FDS $NFLX $NTES $TMO $DKNG $GMBL $GMAB $SOLY $VIE $XP $ALGT $GRTS $NXTC
-
Henry: @DAN $I $NXTC I wasn't suggesting it was. I thought the news of a hedge fund dumping was scary enough, because that could trigger other hedge funds to dump or short.
I don't quite understand the news. Perhaps $I thought they had some rights to the ... - Henry: $NXTC rocket stock down 50% in premarket. Last weeks news was they had 1 complete remission. Good news, but very preliminary news. They released the actual study Friday after the close, which said the same thing. Perhaps people realized, they still need a Phase2 study.
- gmj: @Henry $NXTC thx For the note made for a nice 3% trade this morning was a little choppy but I held through the noise... thx again.
- Henry: $NXTC up 110% today biotech based on a newly released abstract
- Henry: $NXTC one patient out of 32 had a complete remission, the study group had various types of tumors. Seems kind of thin data to me, but the market is right and it's now up 149%
- sierramp: @Henry $NXTC Who has info on it? I can't find anything. Thank you.
- Henry: $NXTC Stock is in it's 4th trading halt of the day, having peaked at 79.9 (opened at 25) I have to think these are the machines dukeing it out. Current bid ask is 57 -70.4 Fun to watch, np
| Stock Price | $1.36 |
| Change | 5.43% |
| Volume | 43,929 |
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. It is focused on understanding biological pathways, the interactions of cells and the role each interaction plays in an immune response. The company's product candidate, NC318, is a immunomedicine against a immunomodulatory receptor called Siglec-15, or S15.
Request Video of NXTCAlready a member? Sign in here.
Past Month
Leading Peers
-
$11.38 284.74%
-
$13.10 265.59%
-
$6.44 144.38%
Past Month
Lagging Peers
-
$26.55 -85.40%
-
$6.15 -76.75%
-
$13.97 -57.15%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!